Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Особенности репродуктивной функции девочек и женщин с ревматоидным артритом
Особенности репродуктивной функции девочек и женщин с ревматоидным артритом
Казакова А.В., Санталова Г.В., Карташова П.В., Порецкова Г.Ю., Дуфинец И.Е. Особенности репродуктивной функции девочек и женщин с ревматоидным артритом. Гинекология. 2024;26(1):22–27.
DOI: 10.26442/20795696.2024.1.202645
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
DOI: 10.26442/20795696.2024.1.202645
DOI: 10.26442/20795696.2024.1.202645
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
________________________________________________
DOI: 10.26442/20795696.2024.1.202645
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Ревматоидный артрит – одно из наиболее часто встречаемых и тяжелых аутоиммунных заболеваний. Распространенность ревматоидного артрита среди взрослого населения в разных географических зонах мира колеблется от 0,5 до 2%. Распространенность ювенильного идиопатического артрита составляет примерно 6 на 10 тыс. детей. Заболевание у девочек встречается в 2 раза чаще, чем у мальчиков. В некоторых исследованиях продемонстрировано возможное влияние высокой кумулятивной дозы метотрексата на функцию яичников у пациенток с системной красной волчанкой, но необходимы дальнейшие исследования, чтобы подтвердить этот эффект. Анализ литературных данных позволил нам обозначить прогностически значимые факторы развития аутоиммунной овариальной недостаточности у пациенток репродуктивного возраста с ревматической патологией, отметить факт недостающих сведений о состоянии репродуктивной системы у больных женского пола с ювенильным артритом.
Ключевые слова: ювенильный ревматоидный артрит, уровень антимюллерова гормона, аутоиммунная овариальная недостаточность
Keywords: juvenile rheumatoid arthritis, anti-Mullerian hormone level, autoimmune ovarian failure
Ключевые слова: ювенильный ревматоидный артрит, уровень антимюллерова гормона, аутоиммунная овариальная недостаточность
________________________________________________
Keywords: juvenile rheumatoid arthritis, anti-Mullerian hormone level, autoimmune ovarian failure
Полный текст
Список литературы
1. Ревматоидный артрит. Клинические рекомендации. Министерство здравоохранения Российской Федерации. 2021 [Revmatoidnyi artrit. Klinicheskie rekomendatsii. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. 2021 (in Russian)].
2. Huang C, AlSubki L, Yamaya A, et al. Poor ovarian response in assisted reproductive technology cycles is associated with anti-ovarian antibody and pro-inflammatory immune responses. J Reprod Immunol. 2023;160:104152. DOI:10.1016/j.jri.2023.104152
3. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. DOI:10.1016/S0140-6736(16)30173-8
4. Van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol.
2018;32(2):174-87. DOI:10.1016/j.berh.2018.10.005
5. Фоломеева O.M., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяциях взрослого населения России и США. Научно-практическая ревматология. 2008;46(4):4-13 [Folomeeva OM, Galushko EA, Erdes SF. Prevalence of rheumatic diseases in adult populations of Russian Federation and USA. Rheumatology Science and Practice. 2008;46(4):4-13 (in Russian)]. DOI:10.14412/1995-4484-2008-529
6. Общая заболеваемость взрослого населения России в 2017 году. Статистические материалы. Часть IV. Москва. 2018 [Obshchaia zabolevaemost' vzroslogo naseleniia Rossii v 2017 godu. Statisticheskie materialy. Chast' IV. Moscow. 2018 (in Russian)].
7. Мысаева Г.М., Горемыкина М.В., Манабаева Г.К. Ревматоидный артрит и фертильность: обзор литературы. Наука и Здравоохранение. 2019;21(2):38-43 [Myssayeva GM, Goremykina MV, Manabayeva GK. Rheumatoid arthritis and fertility: literature review. Science and Healthcare. 2019;21(2):38-43 (in Russian)].
8. Юношеский артрит с системным началом. Клинические рекомендации. Министерство здравоохранения Российской Федерации. 2021 [Iunosheskii artrit s sistemnym nachalom. Klinicheskie rekomendatsii. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. 2021 (in Russian)].
9. Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum. 2011;63(6):1517-21. DOI:10.1002/art.30327
10. Clowse M, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012;64(5):668-74. DOI:10.1002/acr.21593
11. Brouwer J, Fleurbaaij R, Hazes JM, et al. Subfertility in Women With Rheumatoid Arthritis and the Outcome of Fertility Assessments. Arthritis Care Res (Hoboken).
2017; 69(8):1142-9. DOI:10.1002/acr.23124
12. Перминова С.Г., Власова Г.А., Кошелева Н.М. Репродуктивная функция у женщин с ревматоидным артритом: влияние заболевания и терапии метотрексатом на уровень антимюллерова гормона. Акушерство и гинекология. 2020;(4):104-10 [Perminova SG, Vlasova GA, Kosheleva NM. Reproductive function of women with rheumatoid arthritis: the effect of the disease and methotrexate therapy on the serum level of anti-mullerian hormone. Obstetrics and Gynecology. 2020;(4):104-10 (in Russian)].
DOI:10.18565/aig.2020.4.104-110
13. Турмухамбетова Б.Т., Козлова Л.К., Джуламанова А.Б., Никонова Е.Н. Особенности репродуктивной функции женщин с ревматоидным артритом. Врач. 2020;31(5):18-22 [Turmukhambetova B, Kozlova L, Dzhulamanova A, Nikonova E. The features of reproductive function in women with rheumatoid arthritis. Vrach. 2020;31(5):18-22 (in Russian)]. DOI:10.29296/25877305-2020-05-04
14. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-55. DOI:10.1210/er.2009-0041
15. Kuroda K, Uchida T, Nagai S, et al. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age. J Assist Reprod Genet. 2015;32(2):243-7. DOI:10.1007/s10815-014-0397-7
16. Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril. 2015;104(3):545-53. DOI:10.1016/j.fertnstert.2015.05.028
17. Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019;10:265. DOI:10.3389/fendo.2019.00265
18. Кошелева Н.М., Хузмиева С.И., Алекберова З.С. Системная красная волчанка и беременность. II. Влияние системной красной волчанки на исходы беременности. Научно-практическая ревматология. 2006;44(2):52-9 [Kosheleva NM, Husmieva SI, Alekberova ZS. Systemic lupus erythematosus and pregnancy. II. Influence of systemic lupus erythematosus on pregnancy outcomes. Rheumatology Science and Practice. 2006;44(2):52-9 (in Russian)].
19. Кошелева Н.М., Матьянова Е.В. Ревматоидный артрит и беременность. Научно-практическая ревматология. 2014;52(6):589-99 [Kosheleva NM, Matyanova EV. Rheumatoid arthritis and pregnancy. Rheumatology Science and Practice. 2014;52(6):589-99 (in Russian)]. DOI:10.14412/1995-4484-2014-589-599
20. Лила А.М., Трофимов Е.А., Лила В.А. Системная красная волчанка: особенности течения у беременных и варианты терапии. Современная ревматология. 2015;9(3):43-7 [Lila AM, Trofimov EA, Lila VA. Systemic lupus erythematosus: Specific features of its course and therapy options. Modern Rheumatology Journal. 2015;9(3):43-7 (in Russian)]. DOI:10.14412/1996-7012-2015-3-43-47
21. Ванян Р.Э., Менжинская И.В., Долгушина Н.В. Роль аутоиммунных антител в развитии «бедного» овариального ответа в программах вспомогательных репродуктивных технологий (обзор литературы). Проблемы репродукции. 2014;(3):53-7 [Vanyan RE, Menzhinskaya IV, Dolgushina NV. The role of autoimmune antibodies in poor ovarian response in assisted reproductive technologies (a review). Problemy Reproduktsii. 2014;(3):53-7 (in Russian)].
22. Padhy N, Gupta S, Mahla A, et al. Demographic characteristics and clinical profile of poor responders in IVF/ICSI: a comparative study. J Hum Reprod Sci. 2010;3(2):91-4. DOI:10.4103/0974-1208.69343
23. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med. 2002;11(7):585-99. DOI:10.1089/152460902760360540
24. Dragojević-Dikić S, Marisavljević D, Mitrović A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010;9(11):771-4. DOI:10.1016/j.autrev.2010.06.008
25. Putowski L, Darmochwal-Kolarz D, Rolinski J, et al. The immunological profile of infertile women after repeated IVF failure (preliminary study). Eur J Obstet Gynecol Reprod Biol. 2004;112(2):192-6. DOI:10.1016/j.ejogrb.2003.06.012
26. Gleicher N. Antiphospholipid antibodies (aPL) affect in vitro fertilization (IVF) outcome. Am J Reprod Immunol. 2001;46(5):330-1. DOI:10.1034/j.1600-0897.2001.d01-20.x
27. Kelkar RL, Meherji PK, Kadam SS, et al. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol. 2005;66(1):53-67. DOI:10.1016/j.jri.2005.02.003
28. Haller-Kikkatalo K, Salumets A, Uibo R. Review on Autoimmune Reactions in Female Infertility: Antibodies to Follicle Stimulating Hormone. Clin Dev Immunol. 2012;2012:762541. DOI:10.1155/2012/762541
29. Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26(8):555-62. DOI:10.3109/09513590.2010.488773
30. Forges T, Monnier-Barbarino P, Faure GC, Béné MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10(2):163-75. DOI:10.1093/humupd/dmh014
31. Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol. 2007;27(1):16-9. DOI:10.1080/01443610601016685
32. Khizroeva J, Nalli C, Bitsadze V, et al. Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101369. DOI:10.1016/j.beem.2019.101369
33. Eudy AM, McDaniel G, Hurd WW, Clowse MEB. Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis. J Rheumatol. 2019;46(5):455-9. DOI:10.3899/jrheum.180176
34. Ferreira GRV, Tomioka RB, Aikawa NE, et al. Ovarian reserve in young juvenile idiopathic arthritis patients. Mod Rheumatol. 2019;29(3):447-51. DOI:10.1080/14397595.2018.1465646
35. Van Pelt Ph, Hokken-Koelega A, Dolhain R, et al. Puberty and disease activity in JIA. From 21st European Pediatric Rheumatology (PReS) Congress. Belgrade, Serbia. 17–21 September 2014. Pediatric Rheumatology. 2014;12(Suppl. 1):P151. DOI:10.1186/1546-0096-12-S1-P151
36. Packham JC, Hall MA. Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol. 2003;21(3):347-50. PMID: 12846055
37. Koker O, Sahin S, Adrovic A, et al. A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy. Int J Rheum Dis. 2020;23(9):1210-8. DOI:10.1111/1756-185x.13906
38. Barut K, Şahin S, Adrovic A, et al. Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy. Turk J Med Sci. 2018;48(6):1109-14.
DOI:10.3906/sag-1710-190
39. Кричевская О.А., Гандалоева З.М., Дубинина Т.В. Анкилозирующий спондилит и беременность: современный взгляд на проблему. Современная ревматология. 2018;12(3):19-28 [Krichevskaya OA, Gandaloeva ZM, Dubinina TV. Ankylosing spondylitis and pregnancy: a current view on the problem. Modern Rheumatology Journal. 2018;12(3):19-28 (in Russian)]. DOI:10.14412/1996-7012-2018-3-19-28
40. Salman S, Sherif B, Al-Zohyri A. OP0131 Effects of Some Non Steroidal Anti-Inflammatory Drugs on Ovulation in Women with Mild Musculoskeletal Pain. Ann Rheum Dis. 2015;74:117-8. DOI:10.1136/annrheumdis-2015-eular.1062
41. Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795-810. DOI:10.1136/annrheumdis-2015-208840
42. Козлов С.Н., Зузова А.П., Белькова Ю.А. Глюкокортикоидные препараты. 3-е изд. Смоленск: МАКМАХ, 2014 [Kozlov SN, Zuzova AP, Bel'kova IuA. Gliukokortikoidnye preparaty. 3-e izd. Smolensk: MAKMAKh, 2014 (in Russian)].
43. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. DOI:10.1186/1710-1492-9-30
44. Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford). 2008;47(Suppl. 3):iii38-41. DOI:10.1093/rheumatology/ken156
45. Huong DL, Amoura Z, Duhaut P, et al. Risk of failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol. 2002;29(12):2571-6. PMID: 12465154
46. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160(5):610-9. DOI:10.1001/archinte.160.5.610
47. De Araujo DB, Yamakami LY, Aikawa NE, et al. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43(6):503-11. DOI:10.3109/03009742.2014.908237
48. Алекберова З.С., Бижанова Д.А. Болезнь Бехчета: репродуктивная функция и беременность. Современная ревматология. 2018;12(2):103-6 [Alekberova ZS, Bizhanova DA. Behсet's disease: reproductive function and pregnancy. Modern Rheumatology Journal. 2018;12(2):103-6 (in Russian)]. DOI:10.14412/1996-7012-2018-2-103-106
49. Granger E, Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62(2):238-56. DOI:10.1097/GRF.0000000000000436
50. Марченко Л.А., Машаева Р.И. Клинико-лабораторные критерии оккультной формы преждевременной недостаточности яичников. Гинекология. 2018;20(6):73-6 [Marchenko LA, Mashaeva RI. Clinical and laboratory criteria for occult form of premature ovarian failure. Ginecology. 2018;20(6):73-6 (in Russian)]. DOI:10.26442/20795696.2018.6.180069
51. Ткаченко Л.В., Гриценко И.А., Тихаева К.Ю., и др. Оценка факторов риска и прогнозирование преждевременной недостаточности яичников. Акушерство, Гинекология и Репродукция. 2022;16(1):73-80 [Tkachenko LV, Gritsenko IA, Tikhaeva KYu, et al. Assessment of risk factors and prediction of premature ovarian failure. Obstetrics, Gynecology and Reproduction. 2022;16(1):73-80 (in Russian)]. DOI:10.17749/2313-7347/ob.gyn.rep.2021.273
52. Jiao X, Meng T, Zhai Y, et al. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies. Front Endocrinol (Lausanne). 2021;12:601752. DOI:10.3389/fendo.2021.601752
53. Гузов И.И., Печерина Е.Ю., Ружанская А.В., и др. Определение референтных интервалов антимюллерова гормона, специфичных для российской популяции. Лабораторная служба. 2019;8(2):25-35 [Guzov II, Pecherina ЕYu, Ruzhanskaya АV, et al. Derivation of reference intervals for Antimullerian hormone, specific for russian population. Laboratory Service. 2019;8(2):25-35 (in Russian)]. DOI:10.17116/labs2019802125
54. Alexander VM, Ashley-Martin J, Riley JK, et al. Association between arthritis treatments and ovarian reserve: a prospective study. Reprod Biomed Online. 2021;42(6):1203-10. DOI:10.1016/j.rbmo.2021.03.018
55. Zhang XH, Zhang YA, Chen X, et al. Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2022;183(4):462-9. DOI:10.1159/000520133
56. Ozer Y, Yildiz M, Turan H, et al. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs. Clin Rheumatol.
2023;43(1):399-406. DOI:10.1007/s10067-023-06747-w
57. Tuohy VK, Altuntas CZ. Autoimmunity and premature ovarian failure. Curr Opin Obstet Gynecol. 2007;19(4):366-9. DOI:10.1097/GCO.0b013e328220e90c
58. Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc. 1979;54(6):394-400.
59. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol. 1985;9(1):23-4. DOI:10.1111/j.1600-0897.1985.tb00336.x
60. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 1986;68(6):850-4.
61. Fenichel P, Sosset C, Barbarino-Monnier P, et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod. 1997;12(12):2623-8. DOI:10.1093/humrep/12.12.2623
62. Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab. 1990;70(1):69-75. DOI:10.1210/jcem-70-1-69
63. Meyer WR, Lavy G, DeCherney AH, et al. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990;75(5):795-9.
64. Shivers CA, Dunbar BS. Autoantibodies to zona pellucida: a possible cause for infertility in women. Science. 1977;197(4308):1082-4. DOI:10.1126/science.70076
65. Singh J, Mhaskar AM. Enzyme-linked immunosorbent determination of autoantibodies to zona pellucida as a possible cause of infertility in women. J Immunol Methods. 1985;79(1):133-41. DOI:10.1016/0022-1759(85)90399-0
66. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, et al. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril. 1991;56(5):928-32. DOI:10.1016/s0015-0282(16)54667-6
67. Luborsky J, Llanes B, Davies S, et al. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol. 1999;90(3):368-74. DOI:10.1006/clim.1998.4661
68. Petríková J, Pura M, Lazúrová I. Antibodies to Gonadal and Adrenal Tissue. In: Autoantibodies (3rd Edition). Elsevier. 2014:391-405. DOI:10.1016/B978-0-444-56378-1.00047-2
69. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1966;2(7457):264-5. DOI:10.1016/s0140-6736(66)92546-3
70. Царегородцева М.В. Аутоиммунная овариальная недостаточность воспалительного генеза. Журнал акушерства и женских болезней. 2008;2:37-42 [Tsaregorodtseva MV. Autoimmunnaia ovarial'naia nedostatochnost' vospalitel'nogo geneza. Zhurnal Akusherstva i Zhenskikh Boleznei. 2008;2:37-42 (in Russian)].
71. Иоселиани Т.Г. Антигены системы HLA при аутоиммунном оофорите. Вестник Ассоциации эндокринологов Санкт-Петербурга. 2000;1(8):4 [Ioseliani TG. Antigeny sistemy HLA pri autoimmunnom ooforite. Vestnik Assotsiatsii endokrinologov Sankt-Peterburga. 2000;1(8):4 (in Russian)].
72. Coulam CB, Tung KS. Autoimmune basis of premature ovarian failure. Immunol Allergy Clin North Am. 1994;14(4):739-52. DOI:10.1016/S0889-8561(22)00339-3
73. Yu-Rice Y, Edassery SL, Urban N, et al. Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer. Reproduction. 2017;153(3):277-84. DOI:10.1530/REP-16-0265
74. Pires ES, Khole VV. Anti-ovarian antibodies: Specificity, prevalence, multiple antigenicity and significance in human ovarian autoimmunity. In: Current Paradigm of Reproductive Immunology. Trivandrum, India. 2009:159-190.
75. Pires ES. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet. 2010;27(9-10):519-24. DOI:10.1007/s10815-010-9440-5
76. McNatty KP. Cyclic changes in antral fluid hormone concentrations in humans. Clin Endocrinol Metab. 1978;7(3):577-600. DOI:10.1016/s0300-595x(78)80010-3
77. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol. 2001;32(1):76-91. DOI:10.1002/ppul.1092
78. Cameron IT, O'Shea FC, Rolland JM, et al. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab. 1988;67(6):1190-4. DOI:10.1210/jcem-67-6-1190
79. Luborsky J, Pong R. Pregnancy outcome and ovarian antibodies in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol. 2000;44(5):261-5. DOI:10.1111/j.8755-8920.2000.440502.x
80. Sharif K, Watad A, Bridgewood C, et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101323. DOI:10.1016/j.beem.2019.101323
81. Irvine WJ, Chan MM, Scarth L, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet. 1968;2(7574):883-7. DOI:10.1016/s0140-6736(68)91053-2
82. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19. DOI:10.1056/NEJMra1004965
2. Huang C, AlSubki L, Yamaya A, et al. Poor ovarian response in assisted reproductive technology cycles is associated with anti-ovarian antibody and pro-inflammatory immune responses. J Reprod Immunol. 2023;160:104152. DOI:10.1016/j.jri.2023.104152
3. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. DOI:10.1016/S0140-6736(16)30173-8
4. Van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol.
2018;32(2):174-87. DOI:10.1016/j.berh.2018.10.005
5. Folomeeva OM, Galushko EA, Erdes SF. Prevalence of rheumatic diseases in adult populations of Russian Federation and USA. Rheumatology Science and Practice. 2008;46(4):4-13 (in Russian). DOI:10.14412/1995-4484-2008-529
6. Obshchaia zabolevaemost' vzroslogo naseleniia Rossii v 2017 godu. Statisticheskie materialy. Chast' IV. Moscow. 2018 (in Russian).
7. Myssayeva GM, Goremykina MV, Manabayeva GK. Rheumatoid arthritis and fertility: literature review. Science and Healthcare. 2019;21(2):38-43 (in Russian).
8. Iunosheskii artrit s sistemnym nachalom. Klinicheskie rekomendatsii. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. 2021 (in Russian).
9. Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum. 2011;63(6):1517-21. DOI:10.1002/art.30327
10. Clowse M, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012;64(5):668-74. DOI:10.1002/acr.21593
11. Brouwer J, Fleurbaaij R, Hazes JM, et al. Subfertility in Women With Rheumatoid Arthritis and the Outcome of Fertility Assessments. Arthritis Care Res (Hoboken).
2017; 69(8):1142-9. DOI:10.1002/acr.23124
12. Perminova SG, Vlasova GA, Kosheleva NM. Reproductive function of women with rheumatoid arthritis: the effect of the disease and methotrexate therapy on the serum level of anti-mullerian hormone. Obstetrics and Gynecology. 2020;(4):104-10 (in Russian). DOI:10.18565/aig.2020.4.104-110
13. Turmukhambetova B, Kozlova L, Dzhulamanova A, Nikonova E. The features of reproductive function in women with rheumatoid arthritis. Vrach. 2020;31(5):18-22 (in Russian). DOI:10.29296/25877305-2020-05-04
14. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-55. DOI:10.1210/er.2009-0041
15. Kuroda K, Uchida T, Nagai S, et al. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age. J Assist Reprod Genet. 2015;32(2):243-7. DOI:10.1007/s10815-014-0397-7
16. Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril. 2015;104(3):545-53. DOI:10.1016/j.fertnstert.2015.05.028
17. Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019;10:265. DOI:10.3389/fendo.2019.00265
18. Kosheleva NM, Husmieva SI, Alekberova ZS. Systemic lupus erythematosus and pregnancy. II. Influence of systemic lupus erythematosus on pregnancy outcomes. Rheumatology Science and Practice. 2006;44(2):52-9 (in Russian).
19. Kosheleva NM, Matyanova EV. Rheumatoid arthritis and pregnancy. Rheumatology Science and Practice. 2014;52(6):589-99 (in Russian). DOI:10.14412/1995-4484-2014-589-599
20. Lila AM, Trofimov EA, Lila VA. Systemic lupus erythematosus: Specific features of its course and therapy options. Modern Rheumatology Journal. 2015;9(3):43-7 (in Russian). DOI:10.14412/1996-7012-2015-3-43-47
21. Vanyan RE, Menzhinskaya IV, Dolgushina NV. The role of autoimmune antibodies in poor ovarian response in assisted reproductive technologies (a review). Problemy Reproduktsii. 2014;(3):53-7 (in Russian).
22. Padhy N, Gupta S, Mahla A, et al. Demographic characteristics and clinical profile of poor responders in IVF/ICSI: a comparative study. J Hum Reprod Sci. 2010;3(2):91-4. DOI:10.4103/0974-1208.69343
23. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med. 2002;11(7):585-99. DOI:10.1089/152460902760360540
24. Dragojević-Dikić S, Marisavljević D, Mitrović A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010;9(11):771-4. DOI:10.1016/j.autrev.2010.06.008
25. Putowski L, Darmochwal-Kolarz D, Rolinski J, et al. The immunological profile of infertile women after repeated IVF failure (preliminary study). Eur J Obstet Gynecol Reprod Biol. 2004;112(2):192-6. DOI:10.1016/j.ejogrb.2003.06.012
26. Gleicher N. Antiphospholipid antibodies (aPL) affect in vitro fertilization (IVF) outcome. Am J Reprod Immunol. 2001;46(5):330-1. DOI:10.1034/j.1600-0897.2001.d01-20.x
27. Kelkar RL, Meherji PK, Kadam SS, et al. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol. 2005;66(1):53-67. DOI:10.1016/j.jri.2005.02.003
28. Haller-Kikkatalo K, Salumets A, Uibo R. Review on Autoimmune Reactions in Female Infertility: Antibodies to Follicle Stimulating Hormone. Clin Dev Immunol. 2012;2012:762541. DOI:10.1155/2012/762541
29. Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26(8):555-62. DOI:10.3109/09513590.2010.488773
30. Forges T, Monnier-Barbarino P, Faure GC, Béné MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10(2):163-75. DOI:10.1093/humupd/dmh014
31. Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol. 2007;27(1):16-9. DOI:10.1080/01443610601016685
32. Khizroeva J, Nalli C, Bitsadze V, et al. Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101369. DOI:10.1016/j.beem.2019.101369
33. Eudy AM, McDaniel G, Hurd WW, Clowse MEB. Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis. J Rheumatol. 2019;46(5):455-9. DOI:10.3899/jrheum.180176
34. Ferreira GRV, Tomioka RB, Aikawa NE, et al. Ovarian reserve in young juvenile idiopathic arthritis patients. Mod Rheumatol. 2019;29(3):447-51. DOI:10.1080/14397595.2018.1465646
35. Van Pelt Ph, Hokken-Koelega A, Dolhain R, et al. Puberty and disease activity in JIA. From 21st European Pediatric Rheumatology (PReS) Congress. Belgrade, Serbia. 17–21 September 2014. Pediatric Rheumatology. 2014;12(Suppl. 1):P151. DOI:10.1186/1546-0096-12-S1-P151
36. Packham JC, Hall MA. Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol. 2003;21(3):347-50. PMID: 12846055
37. Koker O, Sahin S, Adrovic A, et al. A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy. Int J Rheum Dis. 2020;23(9):1210-8. DOI:10.1111/1756-185x.13906
38. Barut K, Şahin S, Adrovic A, et al. Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy. Turk J Med Sci. 2018;48(6):1109-14.
DOI:10.3906/sag-1710-190
39. Krichevskaya OA, Gandaloeva ZM, Dubinina TV. Ankylosing spondylitis and pregnancy: a current view on the problem. Modern Rheumatology Journal. 2018;12(3):19-28 (in Russian). DOI:10.14412/1996-7012-2018-3-19-28
40. Salman S, Sherif B, Al-Zohyri A. OP0131 Effects of Some Non Steroidal Anti-Inflammatory Drugs on Ovulation in Women with Mild Musculoskeletal Pain. Ann Rheum Dis. 2015;74:117-8. DOI:10.1136/annrheumdis-2015-eular.1062
41. Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795-810. DOI:10.1136/annrheumdis-2015-208840
42. Kozlov SN, Zuzova AP, Bel'kova IuA. Gliukokortikoidnye preparaty. 3-e izd. Smolensk: MAKMAKh, 2014 (in Russian).
43. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. DOI:10.1186/1710-1492-9-30
44. Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford). 2008;47(Suppl. 3):iii38-41. DOI:10.1093/rheumatology/ken156
45. Huong DL, Amoura Z, Duhaut P, et al. Risk of failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol. 2002;29(12):2571-6. PMID: 12465154
46. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160(5):610-9. DOI:10.1001/archinte.160.5.610
47. De Araujo DB, Yamakami LY, Aikawa NE, et al. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43(6):503-11. DOI:10.3109/03009742.2014.908237
48. Alekberova ZS, Bizhanova DA. Behсet's disease: reproductive function and pregnancy. Modern Rheumatology Journal. 2018;12(2):103-6 (in Russian).
DOI:10.14412/1996-7012-2018-2-103-106
49. Granger E, Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62(2):238-56. DOI:10.1097/GRF.0000000000000436
50. Marchenko LA, Mashaeva RI. Clinical and laboratory criteria for occult form of premature ovarian failure. Ginecology. 2018;20(6):73-6 (in Russian). DOI:10.26442/20795696.2018.6.180069
51. Tkachenko LV, Gritsenko IA, Tikhaeva KYu, et al. Assessment of risk factors and prediction of premature ovarian failure. Obstetrics, Gynecology and Reproduction. 2022;16(1):73-80 (in Russian). DOI:10.17749/2313-7347/ob.gyn.rep.2021.273
52. Jiao X, Meng T, Zhai Y, et al. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies. Front Endocrinol (Lausanne). 2021;12:601752. DOI:10.3389/fendo.2021.601752
53. Guzov II, Pecherina ЕYu, Ruzhanskaya АV, et al. Derivation of reference intervals for Antimullerian hormone, specific for russian population. Laboratory Service. 2019;8(2):25-35 (in Russian). DOI:10.17116/labs2019802125
54. Alexander VM, Ashley-Martin J, Riley JK, et al. Association between arthritis treatments and ovarian reserve: a prospective study. Reprod Biomed Online. 2021;42(6):1203-10. DOI:10.1016/j.rbmo.2021.03.018
55. Zhang XH, Zhang YA, Chen X, et al. Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2022;183(4):462-9. DOI:10.1159/000520133
56. Ozer Y, Yildiz M, Turan H, et al. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs. Clin Rheumatol.
2023;43(1):399-406. DOI:10.1007/s10067-023-06747-w
57. Tuohy VK, Altuntas CZ. Autoimmunity and premature ovarian failure. Curr Opin Obstet Gynecol. 2007;19(4):366-9. DOI:10.1097/GCO.0b013e328220e90c
58. Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc. 1979;54(6):394-400.
59. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol. 1985;9(1):23-4. DOI:10.1111/j.1600-0897.1985.tb00336.x
60. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 1986;68(6):850-4.
61. Fenichel P, Sosset C, Barbarino-Monnier P, et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod. 1997;12(12):2623-8. DOI:10.1093/humrep/12.12.2623
62. Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab. 1990;70(1):69-75. DOI:10.1210/jcem-70-1-69
63. Meyer WR, Lavy G, DeCherney AH, et al. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990;75(5):795-9.
64. Shivers CA, Dunbar BS. Autoantibodies to zona pellucida: a possible cause for infertility in women. Science. 1977;197(4308):1082-4. DOI:10.1126/science.70076
65. Singh J, Mhaskar AM. Enzyme-linked immunosorbent determination of autoantibodies to zona pellucida as a possible cause of infertility in women. J Immunol Methods. 1985;79(1):133-41. DOI:10.1016/0022-1759(85)90399-0
66. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, et al. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril. 1991;56(5):928-32. DOI:10.1016/s0015-0282(16)54667-6
67. Luborsky J, Llanes B, Davies S, et al. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol. 1999;90(3):368-74. DOI:10.1006/clim.1998.4661
68. Petríková J, Pura M, Lazúrová I. Antibodies to Gonadal and Adrenal Tissue. In: Autoantibodies (3rd Edition). Elsevier. 2014:391-405. DOI:10.1016/B978-0-444-56378-1.00047-2
69. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1966;2(7457):264-5. DOI:10.1016/s0140-6736(66)92546-3
70. Tsaregorodtseva MV. Autoimmunnaia ovarial'naia nedostatochnost' vospalitel'nogo geneza. Zhurnal Akusherstva i Zhenskikh Boleznei. 2008;2:37-42 (in Russian).
71. Ioseliani TG. Antigeny sistemy HLA pri autoimmunnom ooforite. Vestnik Assotsiatsii endokrinologov Sankt-Peterburga. 2000;1(8):4 (in Russian).
72. Coulam CB, Tung KS. Autoimmune basis of premature ovarian failure. Immunol Allergy Clin North Am. 1994;14(4):739-52. DOI:10.1016/S0889-8561(22)00339-3
73. Yu-Rice Y, Edassery SL, Urban N, et al. Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer. Reproduction. 2017;153(3):277-84. DOI:10.1530/REP-16-0265
74. Pires ES, Khole VV. Anti-ovarian antibodies: Specificity, prevalence, multiple antigenicity and significance in human ovarian autoimmunity. In: Current Paradigm of Reproductive Immunology. Trivandrum, India. 2009:159-190.
75. Pires ES. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet. 2010;27(9-10):519-24. DOI:10.1007/s10815-010-9440-5
76. McNatty KP. Cyclic changes in antral fluid hormone concentrations in humans. Clin Endocrinol Metab. 1978;7(3):577-600. DOI:10.1016/s0300-595x(78)80010-3
77. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol. 2001;32(1):76-91. DOI:10.1002/ppul.1092
78. Cameron IT, O'Shea FC, Rolland JM, et al. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab. 1988;67(6):1190-4. DOI:10.1210/jcem-67-6-1190
79. Luborsky J, Pong R. Pregnancy outcome and ovarian antibodies in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol. 2000;44(5):261-5. DOI:10.1111/j.8755-8920.2000.440502.x
80. Sharif K, Watad A, Bridgewood C, et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101323. DOI:10.1016/j.beem.2019.101323
81. Irvine WJ, Chan MM, Scarth L, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet. 1968;2(7574):883-7. DOI:10.1016/s0140-6736(68)91053-2
82. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19. DOI:10.1056/NEJMra1004965
2. Huang C, AlSubki L, Yamaya A, et al. Poor ovarian response in assisted reproductive technology cycles is associated with anti-ovarian antibody and pro-inflammatory immune responses. J Reprod Immunol. 2023;160:104152. DOI:10.1016/j.jri.2023.104152
3. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. DOI:10.1016/S0140-6736(16)30173-8
4. Van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol.
2018;32(2):174-87. DOI:10.1016/j.berh.2018.10.005
5. Фоломеева O.M., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяциях взрослого населения России и США. Научно-практическая ревматология. 2008;46(4):4-13 [Folomeeva OM, Galushko EA, Erdes SF. Prevalence of rheumatic diseases in adult populations of Russian Federation and USA. Rheumatology Science and Practice. 2008;46(4):4-13 (in Russian)]. DOI:10.14412/1995-4484-2008-529
6. Общая заболеваемость взрослого населения России в 2017 году. Статистические материалы. Часть IV. Москва. 2018 [Obshchaia zabolevaemost' vzroslogo naseleniia Rossii v 2017 godu. Statisticheskie materialy. Chast' IV. Moscow. 2018 (in Russian)].
7. Мысаева Г.М., Горемыкина М.В., Манабаева Г.К. Ревматоидный артрит и фертильность: обзор литературы. Наука и Здравоохранение. 2019;21(2):38-43 [Myssayeva GM, Goremykina MV, Manabayeva GK. Rheumatoid arthritis and fertility: literature review. Science and Healthcare. 2019;21(2):38-43 (in Russian)].
8. Юношеский артрит с системным началом. Клинические рекомендации. Министерство здравоохранения Российской Федерации. 2021 [Iunosheskii artrit s sistemnym nachalom. Klinicheskie rekomendatsii. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. 2021 (in Russian)].
9. Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum. 2011;63(6):1517-21. DOI:10.1002/art.30327
10. Clowse M, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012;64(5):668-74. DOI:10.1002/acr.21593
11. Brouwer J, Fleurbaaij R, Hazes JM, et al. Subfertility in Women With Rheumatoid Arthritis and the Outcome of Fertility Assessments. Arthritis Care Res (Hoboken).
2017; 69(8):1142-9. DOI:10.1002/acr.23124
12. Перминова С.Г., Власова Г.А., Кошелева Н.М. Репродуктивная функция у женщин с ревматоидным артритом: влияние заболевания и терапии метотрексатом на уровень антимюллерова гормона. Акушерство и гинекология. 2020;(4):104-10 [Perminova SG, Vlasova GA, Kosheleva NM. Reproductive function of women with rheumatoid arthritis: the effect of the disease and methotrexate therapy on the serum level of anti-mullerian hormone. Obstetrics and Gynecology. 2020;(4):104-10 (in Russian)].
DOI:10.18565/aig.2020.4.104-110
13. Турмухамбетова Б.Т., Козлова Л.К., Джуламанова А.Б., Никонова Е.Н. Особенности репродуктивной функции женщин с ревматоидным артритом. Врач. 2020;31(5):18-22 [Turmukhambetova B, Kozlova L, Dzhulamanova A, Nikonova E. The features of reproductive function in women with rheumatoid arthritis. Vrach. 2020;31(5):18-22 (in Russian)]. DOI:10.29296/25877305-2020-05-04
14. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-55. DOI:10.1210/er.2009-0041
15. Kuroda K, Uchida T, Nagai S, et al. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age. J Assist Reprod Genet. 2015;32(2):243-7. DOI:10.1007/s10815-014-0397-7
16. Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril. 2015;104(3):545-53. DOI:10.1016/j.fertnstert.2015.05.028
17. Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019;10:265. DOI:10.3389/fendo.2019.00265
18. Кошелева Н.М., Хузмиева С.И., Алекберова З.С. Системная красная волчанка и беременность. II. Влияние системной красной волчанки на исходы беременности. Научно-практическая ревматология. 2006;44(2):52-9 [Kosheleva NM, Husmieva SI, Alekberova ZS. Systemic lupus erythematosus and pregnancy. II. Influence of systemic lupus erythematosus on pregnancy outcomes. Rheumatology Science and Practice. 2006;44(2):52-9 (in Russian)].
19. Кошелева Н.М., Матьянова Е.В. Ревматоидный артрит и беременность. Научно-практическая ревматология. 2014;52(6):589-99 [Kosheleva NM, Matyanova EV. Rheumatoid arthritis and pregnancy. Rheumatology Science and Practice. 2014;52(6):589-99 (in Russian)]. DOI:10.14412/1995-4484-2014-589-599
20. Лила А.М., Трофимов Е.А., Лила В.А. Системная красная волчанка: особенности течения у беременных и варианты терапии. Современная ревматология. 2015;9(3):43-7 [Lila AM, Trofimov EA, Lila VA. Systemic lupus erythematosus: Specific features of its course and therapy options. Modern Rheumatology Journal. 2015;9(3):43-7 (in Russian)]. DOI:10.14412/1996-7012-2015-3-43-47
21. Ванян Р.Э., Менжинская И.В., Долгушина Н.В. Роль аутоиммунных антител в развитии «бедного» овариального ответа в программах вспомогательных репродуктивных технологий (обзор литературы). Проблемы репродукции. 2014;(3):53-7 [Vanyan RE, Menzhinskaya IV, Dolgushina NV. The role of autoimmune antibodies in poor ovarian response in assisted reproductive technologies (a review). Problemy Reproduktsii. 2014;(3):53-7 (in Russian)].
22. Padhy N, Gupta S, Mahla A, et al. Demographic characteristics and clinical profile of poor responders in IVF/ICSI: a comparative study. J Hum Reprod Sci. 2010;3(2):91-4. DOI:10.4103/0974-1208.69343
23. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med. 2002;11(7):585-99. DOI:10.1089/152460902760360540
24. Dragojević-Dikić S, Marisavljević D, Mitrović A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010;9(11):771-4. DOI:10.1016/j.autrev.2010.06.008
25. Putowski L, Darmochwal-Kolarz D, Rolinski J, et al. The immunological profile of infertile women after repeated IVF failure (preliminary study). Eur J Obstet Gynecol Reprod Biol. 2004;112(2):192-6. DOI:10.1016/j.ejogrb.2003.06.012
26. Gleicher N. Antiphospholipid antibodies (aPL) affect in vitro fertilization (IVF) outcome. Am J Reprod Immunol. 2001;46(5):330-1. DOI:10.1034/j.1600-0897.2001.d01-20.x
27. Kelkar RL, Meherji PK, Kadam SS, et al. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol. 2005;66(1):53-67. DOI:10.1016/j.jri.2005.02.003
28. Haller-Kikkatalo K, Salumets A, Uibo R. Review on Autoimmune Reactions in Female Infertility: Antibodies to Follicle Stimulating Hormone. Clin Dev Immunol. 2012;2012:762541. DOI:10.1155/2012/762541
29. Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26(8):555-62. DOI:10.3109/09513590.2010.488773
30. Forges T, Monnier-Barbarino P, Faure GC, Béné MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10(2):163-75. DOI:10.1093/humupd/dmh014
31. Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol. 2007;27(1):16-9. DOI:10.1080/01443610601016685
32. Khizroeva J, Nalli C, Bitsadze V, et al. Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101369. DOI:10.1016/j.beem.2019.101369
33. Eudy AM, McDaniel G, Hurd WW, Clowse MEB. Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis. J Rheumatol. 2019;46(5):455-9. DOI:10.3899/jrheum.180176
34. Ferreira GRV, Tomioka RB, Aikawa NE, et al. Ovarian reserve in young juvenile idiopathic arthritis patients. Mod Rheumatol. 2019;29(3):447-51. DOI:10.1080/14397595.2018.1465646
35. Van Pelt Ph, Hokken-Koelega A, Dolhain R, et al. Puberty and disease activity in JIA. From 21st European Pediatric Rheumatology (PReS) Congress. Belgrade, Serbia. 17–21 September 2014. Pediatric Rheumatology. 2014;12(Suppl. 1):P151. DOI:10.1186/1546-0096-12-S1-P151
36. Packham JC, Hall MA. Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol. 2003;21(3):347-50. PMID: 12846055
37. Koker O, Sahin S, Adrovic A, et al. A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy. Int J Rheum Dis. 2020;23(9):1210-8. DOI:10.1111/1756-185x.13906
38. Barut K, Şahin S, Adrovic A, et al. Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy. Turk J Med Sci. 2018;48(6):1109-14.
DOI:10.3906/sag-1710-190
39. Кричевская О.А., Гандалоева З.М., Дубинина Т.В. Анкилозирующий спондилит и беременность: современный взгляд на проблему. Современная ревматология. 2018;12(3):19-28 [Krichevskaya OA, Gandaloeva ZM, Dubinina TV. Ankylosing spondylitis and pregnancy: a current view on the problem. Modern Rheumatology Journal. 2018;12(3):19-28 (in Russian)]. DOI:10.14412/1996-7012-2018-3-19-28
40. Salman S, Sherif B, Al-Zohyri A. OP0131 Effects of Some Non Steroidal Anti-Inflammatory Drugs on Ovulation in Women with Mild Musculoskeletal Pain. Ann Rheum Dis. 2015;74:117-8. DOI:10.1136/annrheumdis-2015-eular.1062
41. Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795-810. DOI:10.1136/annrheumdis-2015-208840
42. Козлов С.Н., Зузова А.П., Белькова Ю.А. Глюкокортикоидные препараты. 3-е изд. Смоленск: МАКМАХ, 2014 [Kozlov SN, Zuzova AP, Bel'kova IuA. Gliukokortikoidnye preparaty. 3-e izd. Smolensk: MAKMAKh, 2014 (in Russian)].
43. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. DOI:10.1186/1710-1492-9-30
44. Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford). 2008;47(Suppl. 3):iii38-41. DOI:10.1093/rheumatology/ken156
45. Huong DL, Amoura Z, Duhaut P, et al. Risk of failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol. 2002;29(12):2571-6. PMID: 12465154
46. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160(5):610-9. DOI:10.1001/archinte.160.5.610
47. De Araujo DB, Yamakami LY, Aikawa NE, et al. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43(6):503-11. DOI:10.3109/03009742.2014.908237
48. Алекберова З.С., Бижанова Д.А. Болезнь Бехчета: репродуктивная функция и беременность. Современная ревматология. 2018;12(2):103-6 [Alekberova ZS, Bizhanova DA. Behсet's disease: reproductive function and pregnancy. Modern Rheumatology Journal. 2018;12(2):103-6 (in Russian)]. DOI:10.14412/1996-7012-2018-2-103-106
49. Granger E, Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62(2):238-56. DOI:10.1097/GRF.0000000000000436
50. Марченко Л.А., Машаева Р.И. Клинико-лабораторные критерии оккультной формы преждевременной недостаточности яичников. Гинекология. 2018;20(6):73-6 [Marchenko LA, Mashaeva RI. Clinical and laboratory criteria for occult form of premature ovarian failure. Ginecology. 2018;20(6):73-6 (in Russian)]. DOI:10.26442/20795696.2018.6.180069
51. Ткаченко Л.В., Гриценко И.А., Тихаева К.Ю., и др. Оценка факторов риска и прогнозирование преждевременной недостаточности яичников. Акушерство, Гинекология и Репродукция. 2022;16(1):73-80 [Tkachenko LV, Gritsenko IA, Tikhaeva KYu, et al. Assessment of risk factors and prediction of premature ovarian failure. Obstetrics, Gynecology and Reproduction. 2022;16(1):73-80 (in Russian)]. DOI:10.17749/2313-7347/ob.gyn.rep.2021.273
52. Jiao X, Meng T, Zhai Y, et al. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies. Front Endocrinol (Lausanne). 2021;12:601752. DOI:10.3389/fendo.2021.601752
53. Гузов И.И., Печерина Е.Ю., Ружанская А.В., и др. Определение референтных интервалов антимюллерова гормона, специфичных для российской популяции. Лабораторная служба. 2019;8(2):25-35 [Guzov II, Pecherina ЕYu, Ruzhanskaya АV, et al. Derivation of reference intervals for Antimullerian hormone, specific for russian population. Laboratory Service. 2019;8(2):25-35 (in Russian)]. DOI:10.17116/labs2019802125
54. Alexander VM, Ashley-Martin J, Riley JK, et al. Association between arthritis treatments and ovarian reserve: a prospective study. Reprod Biomed Online. 2021;42(6):1203-10. DOI:10.1016/j.rbmo.2021.03.018
55. Zhang XH, Zhang YA, Chen X, et al. Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2022;183(4):462-9. DOI:10.1159/000520133
56. Ozer Y, Yildiz M, Turan H, et al. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs. Clin Rheumatol.
2023;43(1):399-406. DOI:10.1007/s10067-023-06747-w
57. Tuohy VK, Altuntas CZ. Autoimmunity and premature ovarian failure. Curr Opin Obstet Gynecol. 2007;19(4):366-9. DOI:10.1097/GCO.0b013e328220e90c
58. Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc. 1979;54(6):394-400.
59. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol. 1985;9(1):23-4. DOI:10.1111/j.1600-0897.1985.tb00336.x
60. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 1986;68(6):850-4.
61. Fenichel P, Sosset C, Barbarino-Monnier P, et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod. 1997;12(12):2623-8. DOI:10.1093/humrep/12.12.2623
62. Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab. 1990;70(1):69-75. DOI:10.1210/jcem-70-1-69
63. Meyer WR, Lavy G, DeCherney AH, et al. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990;75(5):795-9.
64. Shivers CA, Dunbar BS. Autoantibodies to zona pellucida: a possible cause for infertility in women. Science. 1977;197(4308):1082-4. DOI:10.1126/science.70076
65. Singh J, Mhaskar AM. Enzyme-linked immunosorbent determination of autoantibodies to zona pellucida as a possible cause of infertility in women. J Immunol Methods. 1985;79(1):133-41. DOI:10.1016/0022-1759(85)90399-0
66. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, et al. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril. 1991;56(5):928-32. DOI:10.1016/s0015-0282(16)54667-6
67. Luborsky J, Llanes B, Davies S, et al. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol. 1999;90(3):368-74. DOI:10.1006/clim.1998.4661
68. Petríková J, Pura M, Lazúrová I. Antibodies to Gonadal and Adrenal Tissue. In: Autoantibodies (3rd Edition). Elsevier. 2014:391-405. DOI:10.1016/B978-0-444-56378-1.00047-2
69. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1966;2(7457):264-5. DOI:10.1016/s0140-6736(66)92546-3
70. Царегородцева М.В. Аутоиммунная овариальная недостаточность воспалительного генеза. Журнал акушерства и женских болезней. 2008;2:37-42 [Tsaregorodtseva MV. Autoimmunnaia ovarial'naia nedostatochnost' vospalitel'nogo geneza. Zhurnal Akusherstva i Zhenskikh Boleznei. 2008;2:37-42 (in Russian)].
71. Иоселиани Т.Г. Антигены системы HLA при аутоиммунном оофорите. Вестник Ассоциации эндокринологов Санкт-Петербурга. 2000;1(8):4 [Ioseliani TG. Antigeny sistemy HLA pri autoimmunnom ooforite. Vestnik Assotsiatsii endokrinologov Sankt-Peterburga. 2000;1(8):4 (in Russian)].
72. Coulam CB, Tung KS. Autoimmune basis of premature ovarian failure. Immunol Allergy Clin North Am. 1994;14(4):739-52. DOI:10.1016/S0889-8561(22)00339-3
73. Yu-Rice Y, Edassery SL, Urban N, et al. Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer. Reproduction. 2017;153(3):277-84. DOI:10.1530/REP-16-0265
74. Pires ES, Khole VV. Anti-ovarian antibodies: Specificity, prevalence, multiple antigenicity and significance in human ovarian autoimmunity. In: Current Paradigm of Reproductive Immunology. Trivandrum, India. 2009:159-190.
75. Pires ES. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet. 2010;27(9-10):519-24. DOI:10.1007/s10815-010-9440-5
76. McNatty KP. Cyclic changes in antral fluid hormone concentrations in humans. Clin Endocrinol Metab. 1978;7(3):577-600. DOI:10.1016/s0300-595x(78)80010-3
77. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol. 2001;32(1):76-91. DOI:10.1002/ppul.1092
78. Cameron IT, O'Shea FC, Rolland JM, et al. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab. 1988;67(6):1190-4. DOI:10.1210/jcem-67-6-1190
79. Luborsky J, Pong R. Pregnancy outcome and ovarian antibodies in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol. 2000;44(5):261-5. DOI:10.1111/j.8755-8920.2000.440502.x
80. Sharif K, Watad A, Bridgewood C, et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101323. DOI:10.1016/j.beem.2019.101323
81. Irvine WJ, Chan MM, Scarth L, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet. 1968;2(7574):883-7. DOI:10.1016/s0140-6736(68)91053-2
82. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19. DOI:10.1056/NEJMra1004965
________________________________________________
2. Huang C, AlSubki L, Yamaya A, et al. Poor ovarian response in assisted reproductive technology cycles is associated with anti-ovarian antibody and pro-inflammatory immune responses. J Reprod Immunol. 2023;160:104152. DOI:10.1016/j.jri.2023.104152
3. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. DOI:10.1016/S0140-6736(16)30173-8
4. Van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol.
2018;32(2):174-87. DOI:10.1016/j.berh.2018.10.005
5. Folomeeva OM, Galushko EA, Erdes SF. Prevalence of rheumatic diseases in adult populations of Russian Federation and USA. Rheumatology Science and Practice. 2008;46(4):4-13 (in Russian). DOI:10.14412/1995-4484-2008-529
6. Obshchaia zabolevaemost' vzroslogo naseleniia Rossii v 2017 godu. Statisticheskie materialy. Chast' IV. Moscow. 2018 (in Russian).
7. Myssayeva GM, Goremykina MV, Manabayeva GK. Rheumatoid arthritis and fertility: literature review. Science and Healthcare. 2019;21(2):38-43 (in Russian).
8. Iunosheskii artrit s sistemnym nachalom. Klinicheskie rekomendatsii. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. 2021 (in Russian).
9. Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum. 2011;63(6):1517-21. DOI:10.1002/art.30327
10. Clowse M, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012;64(5):668-74. DOI:10.1002/acr.21593
11. Brouwer J, Fleurbaaij R, Hazes JM, et al. Subfertility in Women With Rheumatoid Arthritis and the Outcome of Fertility Assessments. Arthritis Care Res (Hoboken).
2017; 69(8):1142-9. DOI:10.1002/acr.23124
12. Perminova SG, Vlasova GA, Kosheleva NM. Reproductive function of women with rheumatoid arthritis: the effect of the disease and methotrexate therapy on the serum level of anti-mullerian hormone. Obstetrics and Gynecology. 2020;(4):104-10 (in Russian). DOI:10.18565/aig.2020.4.104-110
13. Turmukhambetova B, Kozlova L, Dzhulamanova A, Nikonova E. The features of reproductive function in women with rheumatoid arthritis. Vrach. 2020;31(5):18-22 (in Russian). DOI:10.29296/25877305-2020-05-04
14. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-55. DOI:10.1210/er.2009-0041
15. Kuroda K, Uchida T, Nagai S, et al. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age. J Assist Reprod Genet. 2015;32(2):243-7. DOI:10.1007/s10815-014-0397-7
16. Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril. 2015;104(3):545-53. DOI:10.1016/j.fertnstert.2015.05.028
17. Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019;10:265. DOI:10.3389/fendo.2019.00265
18. Kosheleva NM, Husmieva SI, Alekberova ZS. Systemic lupus erythematosus and pregnancy. II. Influence of systemic lupus erythematosus on pregnancy outcomes. Rheumatology Science and Practice. 2006;44(2):52-9 (in Russian).
19. Kosheleva NM, Matyanova EV. Rheumatoid arthritis and pregnancy. Rheumatology Science and Practice. 2014;52(6):589-99 (in Russian). DOI:10.14412/1995-4484-2014-589-599
20. Lila AM, Trofimov EA, Lila VA. Systemic lupus erythematosus: Specific features of its course and therapy options. Modern Rheumatology Journal. 2015;9(3):43-7 (in Russian). DOI:10.14412/1996-7012-2015-3-43-47
21. Vanyan RE, Menzhinskaya IV, Dolgushina NV. The role of autoimmune antibodies in poor ovarian response in assisted reproductive technologies (a review). Problemy Reproduktsii. 2014;(3):53-7 (in Russian).
22. Padhy N, Gupta S, Mahla A, et al. Demographic characteristics and clinical profile of poor responders in IVF/ICSI: a comparative study. J Hum Reprod Sci. 2010;3(2):91-4. DOI:10.4103/0974-1208.69343
23. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med. 2002;11(7):585-99. DOI:10.1089/152460902760360540
24. Dragojević-Dikić S, Marisavljević D, Mitrović A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010;9(11):771-4. DOI:10.1016/j.autrev.2010.06.008
25. Putowski L, Darmochwal-Kolarz D, Rolinski J, et al. The immunological profile of infertile women after repeated IVF failure (preliminary study). Eur J Obstet Gynecol Reprod Biol. 2004;112(2):192-6. DOI:10.1016/j.ejogrb.2003.06.012
26. Gleicher N. Antiphospholipid antibodies (aPL) affect in vitro fertilization (IVF) outcome. Am J Reprod Immunol. 2001;46(5):330-1. DOI:10.1034/j.1600-0897.2001.d01-20.x
27. Kelkar RL, Meherji PK, Kadam SS, et al. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol. 2005;66(1):53-67. DOI:10.1016/j.jri.2005.02.003
28. Haller-Kikkatalo K, Salumets A, Uibo R. Review on Autoimmune Reactions in Female Infertility: Antibodies to Follicle Stimulating Hormone. Clin Dev Immunol. 2012;2012:762541. DOI:10.1155/2012/762541
29. Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26(8):555-62. DOI:10.3109/09513590.2010.488773
30. Forges T, Monnier-Barbarino P, Faure GC, Béné MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10(2):163-75. DOI:10.1093/humupd/dmh014
31. Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol. 2007;27(1):16-9. DOI:10.1080/01443610601016685
32. Khizroeva J, Nalli C, Bitsadze V, et al. Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101369. DOI:10.1016/j.beem.2019.101369
33. Eudy AM, McDaniel G, Hurd WW, Clowse MEB. Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis. J Rheumatol. 2019;46(5):455-9. DOI:10.3899/jrheum.180176
34. Ferreira GRV, Tomioka RB, Aikawa NE, et al. Ovarian reserve in young juvenile idiopathic arthritis patients. Mod Rheumatol. 2019;29(3):447-51. DOI:10.1080/14397595.2018.1465646
35. Van Pelt Ph, Hokken-Koelega A, Dolhain R, et al. Puberty and disease activity in JIA. From 21st European Pediatric Rheumatology (PReS) Congress. Belgrade, Serbia. 17–21 September 2014. Pediatric Rheumatology. 2014;12(Suppl. 1):P151. DOI:10.1186/1546-0096-12-S1-P151
36. Packham JC, Hall MA. Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). Clin Exp Rheumatol. 2003;21(3):347-50. PMID: 12846055
37. Koker O, Sahin S, Adrovic A, et al. A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy. Int J Rheum Dis. 2020;23(9):1210-8. DOI:10.1111/1756-185x.13906
38. Barut K, Şahin S, Adrovic A, et al. Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy. Turk J Med Sci. 2018;48(6):1109-14.
DOI:10.3906/sag-1710-190
39. Krichevskaya OA, Gandaloeva ZM, Dubinina TV. Ankylosing spondylitis and pregnancy: a current view on the problem. Modern Rheumatology Journal. 2018;12(3):19-28 (in Russian). DOI:10.14412/1996-7012-2018-3-19-28
40. Salman S, Sherif B, Al-Zohyri A. OP0131 Effects of Some Non Steroidal Anti-Inflammatory Drugs on Ovulation in Women with Mild Musculoskeletal Pain. Ann Rheum Dis. 2015;74:117-8. DOI:10.1136/annrheumdis-2015-eular.1062
41. Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795-810. DOI:10.1136/annrheumdis-2015-208840
42. Kozlov SN, Zuzova AP, Bel'kova IuA. Gliukokortikoidnye preparaty. 3-e izd. Smolensk: MAKMAKh, 2014 (in Russian).
43. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. DOI:10.1186/1710-1492-9-30
44. Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford). 2008;47(Suppl. 3):iii38-41. DOI:10.1093/rheumatology/ken156
45. Huong DL, Amoura Z, Duhaut P, et al. Risk of failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol. 2002;29(12):2571-6. PMID: 12465154
46. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160(5):610-9. DOI:10.1001/archinte.160.5.610
47. De Araujo DB, Yamakami LY, Aikawa NE, et al. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43(6):503-11. DOI:10.3109/03009742.2014.908237
48. Alekberova ZS, Bizhanova DA. Behсet's disease: reproductive function and pregnancy. Modern Rheumatology Journal. 2018;12(2):103-6 (in Russian).
DOI:10.14412/1996-7012-2018-2-103-106
49. Granger E, Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62(2):238-56. DOI:10.1097/GRF.0000000000000436
50. Marchenko LA, Mashaeva RI. Clinical and laboratory criteria for occult form of premature ovarian failure. Ginecology. 2018;20(6):73-6 (in Russian). DOI:10.26442/20795696.2018.6.180069
51. Tkachenko LV, Gritsenko IA, Tikhaeva KYu, et al. Assessment of risk factors and prediction of premature ovarian failure. Obstetrics, Gynecology and Reproduction. 2022;16(1):73-80 (in Russian). DOI:10.17749/2313-7347/ob.gyn.rep.2021.273
52. Jiao X, Meng T, Zhai Y, et al. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies. Front Endocrinol (Lausanne). 2021;12:601752. DOI:10.3389/fendo.2021.601752
53. Guzov II, Pecherina ЕYu, Ruzhanskaya АV, et al. Derivation of reference intervals for Antimullerian hormone, specific for russian population. Laboratory Service. 2019;8(2):25-35 (in Russian). DOI:10.17116/labs2019802125
54. Alexander VM, Ashley-Martin J, Riley JK, et al. Association between arthritis treatments and ovarian reserve: a prospective study. Reprod Biomed Online. 2021;42(6):1203-10. DOI:10.1016/j.rbmo.2021.03.018
55. Zhang XH, Zhang YA, Chen X, et al. Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2022;183(4):462-9. DOI:10.1159/000520133
56. Ozer Y, Yildiz M, Turan H, et al. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs. Clin Rheumatol.
2023;43(1):399-406. DOI:10.1007/s10067-023-06747-w
57. Tuohy VK, Altuntas CZ. Autoimmunity and premature ovarian failure. Curr Opin Obstet Gynecol. 2007;19(4):366-9. DOI:10.1097/GCO.0b013e328220e90c
58. Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc. 1979;54(6):394-400.
59. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol. 1985;9(1):23-4. DOI:10.1111/j.1600-0897.1985.tb00336.x
60. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 1986;68(6):850-4.
61. Fenichel P, Sosset C, Barbarino-Monnier P, et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod. 1997;12(12):2623-8. DOI:10.1093/humrep/12.12.2623
62. Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab. 1990;70(1):69-75. DOI:10.1210/jcem-70-1-69
63. Meyer WR, Lavy G, DeCherney AH, et al. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990;75(5):795-9.
64. Shivers CA, Dunbar BS. Autoantibodies to zona pellucida: a possible cause for infertility in women. Science. 1977;197(4308):1082-4. DOI:10.1126/science.70076
65. Singh J, Mhaskar AM. Enzyme-linked immunosorbent determination of autoantibodies to zona pellucida as a possible cause of infertility in women. J Immunol Methods. 1985;79(1):133-41. DOI:10.1016/0022-1759(85)90399-0
66. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, et al. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril. 1991;56(5):928-32. DOI:10.1016/s0015-0282(16)54667-6
67. Luborsky J, Llanes B, Davies S, et al. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol. 1999;90(3):368-74. DOI:10.1006/clim.1998.4661
68. Petríková J, Pura M, Lazúrová I. Antibodies to Gonadal and Adrenal Tissue. In: Autoantibodies (3rd Edition). Elsevier. 2014:391-405. DOI:10.1016/B978-0-444-56378-1.00047-2
69. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1966;2(7457):264-5. DOI:10.1016/s0140-6736(66)92546-3
70. Tsaregorodtseva MV. Autoimmunnaia ovarial'naia nedostatochnost' vospalitel'nogo geneza. Zhurnal Akusherstva i Zhenskikh Boleznei. 2008;2:37-42 (in Russian).
71. Ioseliani TG. Antigeny sistemy HLA pri autoimmunnom ooforite. Vestnik Assotsiatsii endokrinologov Sankt-Peterburga. 2000;1(8):4 (in Russian).
72. Coulam CB, Tung KS. Autoimmune basis of premature ovarian failure. Immunol Allergy Clin North Am. 1994;14(4):739-52. DOI:10.1016/S0889-8561(22)00339-3
73. Yu-Rice Y, Edassery SL, Urban N, et al. Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer. Reproduction. 2017;153(3):277-84. DOI:10.1530/REP-16-0265
74. Pires ES, Khole VV. Anti-ovarian antibodies: Specificity, prevalence, multiple antigenicity and significance in human ovarian autoimmunity. In: Current Paradigm of Reproductive Immunology. Trivandrum, India. 2009:159-190.
75. Pires ES. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet. 2010;27(9-10):519-24. DOI:10.1007/s10815-010-9440-5
76. McNatty KP. Cyclic changes in antral fluid hormone concentrations in humans. Clin Endocrinol Metab. 1978;7(3):577-600. DOI:10.1016/s0300-595x(78)80010-3
77. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol. 2001;32(1):76-91. DOI:10.1002/ppul.1092
78. Cameron IT, O'Shea FC, Rolland JM, et al. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab. 1988;67(6):1190-4. DOI:10.1210/jcem-67-6-1190
79. Luborsky J, Pong R. Pregnancy outcome and ovarian antibodies in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol. 2000;44(5):261-5. DOI:10.1111/j.8755-8920.2000.440502.x
80. Sharif K, Watad A, Bridgewood C, et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101323. DOI:10.1016/j.beem.2019.101323
81. Irvine WJ, Chan MM, Scarth L, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet. 1968;2(7574):883-7. DOI:10.1016/s0140-6736(68)91053-2
82. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19. DOI:10.1056/NEJMra1004965
Авторы
А.В. Казакова*, Г.В. Санталова, П.В. Карташова, Г.Ю. Порецкова, И.Е. Дуфинец
ФГБОУ ВО «Самарский государственный медицинский университет» Минздрава России, Самара, Россия
*a.v.kazakova@samsmu.ru
Samara State Medical University, Samara, Russia
*a.v.kazakova@samsmu.ru
ФГБОУ ВО «Самарский государственный медицинский университет» Минздрава России, Самара, Россия
*a.v.kazakova@samsmu.ru
________________________________________________
Samara State Medical University, Samara, Russia
*a.v.kazakova@samsmu.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.